|
Report Date : |
28.11.2012 |
IDENTIFICATION DETAILS
|
Name : |
ACETO PHARMACEUTICAL ( |
|
|
|
|
Formerly Known As : |
ACETO (SHANGHAI) LTD |
|
|
|
|
Registered Office : |
Room 908, No. 1701, Beijing West Road, Shanghai 200040 PR |
|
|
|
|
Country : |
China |
|
|
|
|
Financials (as on) : |
31.12.2011 |
|
|
|
|
Date of Incorporation : |
18.02.2003 |
|
|
|
|
Com. Reg. No.: |
310115400117446 |
|
|
|
|
Legal Form : |
Wholly Foreign-Owned Enterprise |
|
|
|
|
Line of Business : |
Engaged in Exporting Chemical Products. |
|
|
|
|
No. of Employees : |
25 |
RATING & COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Status : |
Satisfactory |
|
|
|
|
Payment Behaviour : |
Slow but correct |
|
|
|
|
Litigation : |
Clear |
NOTES:
Any query related to this report can be made
on e-mail: infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – June 30th, 2012
|
Country Name |
Previous Rating (31.03.2012) |
Current Rating (30.06.2012) |
|
|
A2 |
A2 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
Since the late 1970s
|
Source : CIA |
ACETO PHARMACEUTICAL (SHANGHAI) LTD.
ROOM 908, NO. 1701, BEIJING WEST ROAD, SHANGHAI 200040 PR CHINA
TEL: 86 (0) 21-62880099
FAX: 86 (0) 21-62884488
Date of Registration : FEBRUARY 18, 2003
REGISTRATION NO. : 310115400117446
LEGAL FORM : WHOLLY FOREIGN-OWNED ENTERPRISE
REGISTERED CAPITAL : USD 400,000
staff :
25
BUSINESS CATEGORY : TRADING
Revenue :
CNY 619,100,000 (AS OF DEC. 31, 2011)
EQUITIES :
CNY 128,760,000 (AS OF DEC. 31, 2011)
WEBSITE : www.aceto.com
E-MAIL :
acetosh@sh.aceto.com
PAYMENT :
AVERAGE
MARKET CONDITION : COMPETITIVE
FINANCIAL CONDITION : FAIRly stable
OPERATIONAL TREND : fairly STEADY
GENERAL REPUTATION : AVERAGE
EXCHANGE RATE :
CNY 6.23 = USD 1
Adopted abbreviations (as follows)
SC - Subject Company (the company inquired by you)
N/A – Not available
CNY – China Yuan Ren Min Bi
This section aims at indicating the relative positions of SC in respect
of its operational trend & general reputation
Operational Trend:- General
Reputation:-
Upward Excellent
Steady Good
Fairly Steady Fairly
Good
Ordinary Average
Fair Fair
Stagnant Detrimental
Downward Not
known
Not known Not
yet be determined
Not yet be determined
SC was established
as a wholly foreign-owned enterprise of PRC with State Administration of
Industry & Commerce (SAIC) under registration No.: 310115400117446 on
February 18, 2003.
SC’s Organization Code Certificate No.:
74727631-2
%20LTD%20%20-%20201799%2028-Nov-2012_files/image003.jpg)
SC’s registered capital: USD 400,000
SC’s paid-in capital: USD 400,000
Registration Change Record:-
|
Date |
Change of Contents |
Before the change |
After the change |
|
-- |
Registration No. |
314111 |
310115400117446 |
|
|
|
|
***Note: SC
changed its Chinese name, while its English name remains the same.
Current Co search indicates SC’s shareholders & chief executives are
as follows:-
|
Name of Shareholder (s) |
% of Shareholding |
|
Aceto Corporation (U.S.A.) |
100 |
SC’s Chief Executives:-
|
Position |
Name |
|
Legal Representative and Chairman |
Gary J. Mo |
No recent development was found during our checks at present.
Aceto Corporation (U.S.A.) 100
--------------------------------------
Aceto Corporation, founded in 1947, is a
global leader in the marketing and distribution of pharmaceutical intermediates
and active ingredients, finished dosage form generics, nutraceutical products,
agricultural protection products and specialty chemicals.
Phone: 516-627-6000
Website: www.aceto.com
E-mail: aceto@aceto.com
Gary J. Mo, Legal Representative, Chairman and General
Manager
---------------------------------------------------------------------------------------
Ø
Gender: M
Ø
Age:
Ø
Nationality: Canada
Ø
Qualification:
University
Ø
Working
experience (s):
At present, working in SC as legal representative and
chairman
Also working in Aceto Pharmaceutical (Shanghai) Ltd.
Branch as principal
SC’s registered business scope includes international trade;
transit trade; trade with the
enterprises within the free trade zone and trade agency; operating business
with enterprises within free trade zone by the enterprises which have right of
import & export; importing &
exporting commodities and technology; simple commercial processing;
commercial consulting services.
SC is mainly engaged in exporting chemical products.
SC’s products mainly include: various chemical products.
SC sources its materials 100% from domestic market. SC sells 100% of its products to overseas market, mainly European and American countries.
The buying terms of SC include Check, T/T and Credit of 30-60 days. The payment terms of SC include Check, L/C, T/T and Credit of 30-60 days.
*Major Customers:
==============
Dana Classic
Fragrances Inc.
Aceto Corp
Golden Mountain
Trading Ltd.
Staff & Office:
--------------------------
SC is known
to have approx. 25 staff at
present.
SC rents an area
as its operating office of approx. 200 sq. meters at the heading address.
n
Aceto Fine Chem GmbH (Hamburg)
n
Aceto France S.A.S.
n
Aceto Health Ingredients GmbH (Hamburg)
n
Aceto Netherlands
n
Aceto Pharma GmbH (Hamburg)
n
Aceto Pharma (India) Private Limited
SC is known to have a
branch at present,
n
Aceto Pharmaceutical (Shanghai) Ltd. Branch
---------------------------------------------------------------------------
Date of Registration: September 20, 2006
Registration No.: 310115500056932
Legal Form: Branch
Company
Overall payment appraisal:
( ) Excellent ( ) Good (X) Average ( ) Fair ( ) Poor ( ) Not yet be determined
The appraisal serves as a reference to reveal SC's payments habits and
ability to pay. It is based on the 3
weighed factors: Trade payment experience (through current enquiry with SC's
suppliers), our delinquent payment and our debt collection record concerning
SC.
Trade payment experience: SC did not
provide any name of trade/service suppliers and we have no other sources to
conduct the enquiry at present.
Delinquent payment record: None in our
database.
Debt collection record: No overdue amount
owed by SC was placed to us for collection within the last 6 years.
Basic Bank:
China Merchants
Bank
AC#: N/a
Balance Sheet
|
Unit: CNY’000 |
As
of Dec. 31, 2010 |
As
of Dec. 31, 2011 |
|
9,220 |
12,170 |
|
|
Notes receivable |
0 |
0 |
|
Accounts
receivable |
190,550 |
213,520 |
|
Advances to
suppliers |
640 |
3,700 |
|
Other receivable |
0 |
0 |
|
Inventory |
0 |
0 |
|
Deferred
expenses |
20 |
70 |
|
Other current
assets |
0 |
0 |
|
|
------------------ |
------------------ |
|
Current assets |
200,430 |
229,460 |
|
Fixed assets |
300 |
260 |
|
Construction in
progress |
0 |
0 |
|
Intangible
assets |
0 |
90 |
|
Long-term
prepaid expenses |
120 |
0 |
|
Deferred income
tax assets |
0 |
0 |
|
Other
non-current assets |
0 |
0 |
|
|
------------------ |
------------------ |
|
Total assets |
200,850 |
229,810 |
|
|
============= |
============= |
|
Short-term loans |
0 |
0 |
|
Notes payable |
1,180 |
2,310 |
|
Accounts payable |
71,670 |
93,750 |
|
Wages payable |
1,110 |
890 |
|
Taxes payable |
700 |
830 |
|
Advances from
clients |
0 |
0 |
|
Other payable |
420 |
2,960 |
|
Other current
liabilities |
180 |
310 |
|
|
------------------ |
------------------ |
|
Current
liabilities |
75,260 |
101,050 |
|
Non-current
liabilities |
0 |
0 |
|
|
------------------ |
------------------ |
|
Total
liabilities |
75,260 |
101,050 |
|
Equities |
125,590 |
128,760 |
|
|
------------------ |
------------------ |
|
Total
liabilities & equities |
200,850 |
229,810 |
|
|
============= |
============= |
Income Statement
|
Unit: CNY’000 |
As of Dec. 31,
2010 |
As of Dec. 31,
2011 |
|
Revenue |
725,030 |
619,100 |
|
Cost of sales |
702,410 |
599,250 |
|
Sales expense |
140 |
440 |
|
Management expense |
9,950 |
10,260 |
|
Finance expense |
3,890 |
4,910 |
|
Profit before
tax |
10,000 |
4,240 |
|
Less: profit tax |
2,270 |
1,070 |
|
7,730 |
3,170 |
Important Ratios
=============
|
|
As
of Dec. 31, 2010 |
As
of Dec. 31, 2011 |
|
*Current ratio |
2.66 |
2.27 |
|
*Quick ratio |
2.66 |
2.27 |
|
*Liabilities
to assets |
0.37 |
0.44 |
|
*Net profit
margin (%) |
1.07 |
0.51 |
|
*Return on
total assets (%) |
3.85 |
1.38 |
|
*Inventory /
Revenue ×365 |
-- |
-- |
|
*Accounts
receivable/ Revenue ×365 |
96 days |
126 days |
|
*
Revenue/Total assets |
3.61 |
2.69 |
|
* Cost of
sales / Revenue |
0.97 |
0.97 |
PROFITABILITY:
AVERAGE
l
The revenue of SC appears fairly good in its line.
l
SC’s net profit margin is average.
l
SC’s return on total assets is average.
l
SC’s cost of sales is fairly high, comparing with
its revenue.
LIQUIDITY: AVERAGE
l
The current ratio of SC is maintained in a fairly
good level.
l
SC’s quick ratio is maintained in a fairly good
level.
l
SC has no inventory in both years.
l
The accounts receivable of SC appears large.
l
SC has no short-term loans in both years.
l
SC’s revenue is in an average level, comparing with
the size of its total assets.
LEVERAGE: AVERAGE
l
The debt ratio of SC is low.
l
The risk for SC to go bankrupt is average.
Overall financial
condition of the SC: Fairly Stable.
SC is considered small-sized in its line with fairly stable financial
conditions. The large amount of accounts receivable may be a threat to SC’s
financial condition.
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.55.70 |
|
UK Pound |
1 |
Rs.89.34 |
|
Euro |
1 |
Rs.72.35 |
INFORMATION DETAILS
|
Report Prepared
by : |
NLM |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest capability
for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
---- |
NB |
New Business |
---- |
This score serves as a reference to assess SC’s credit risk
and to set the amount of credit to be extended. It is calculated from a
composite of weighted scores obtained from each of the major sections of this
report. The assessed factors and their relative weights (as indicated through
%) are as follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history (10%) Market trend (10%) Operational size
(10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.